Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Cubist and Novalon identify small-molecule inhibitors of bacterial enzyme

Oct. 2, 1998

Abbott uses TE-802 as lead to develop broader spectrum ketolides

Oct. 2, 1998

Glaxo Wellcome's MMP inhibitor shows potential in treating sepsis in early clinical study

Oct. 2, 1998

Voriconazole, a promising treatment for serious fungal infections

Oct. 2, 1998

Review of the preclinical activity of GAR-936, a glycylcycline antibiotic with clinical potential

Oct. 2, 1998

MC-02479/RWJ-54428: in vitro activity and pharmacokinetics in animals

Oct. 1, 1998

Results from human pharmacokinetic studies support once-daily dosing for MK-991

Oct. 1, 1998

MEN-10700 highly active against pneumococci, gonococci and meningococci

Oct. 1, 1998

Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D

Oct. 1, 1998

Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.